Kimberly A Forde
Affiliation: University of Pennsylvania
- Risk of myocardial infarction associated with chronic hepatitis C virus infection: a population-based cohort studyK A Forde
Division of Gastroenterology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA
J Viral Hepat 19:271-7. 2012..16; 95% CI, 0.77-1.74). In conclusion, HCV infection was not associated with an increased risk of incident MI...
- Racial and ethnic differences in presentation, etiology, and outcomes of acute liver failure in the United StatesKimberly A Forde
Division of Gastroenterology, Department of Medicine, University of Pennsylvania, 3400 Spruce Street, 3 Ravdin, Philadelphia, Pennsylvania 19104, USA
Clin Gastroenterol Hepatol 7:1121-6. 2009..In patients with chronic liver disease, race plays a role in the rate of survival after transplantation. It is not known how race and ethnicity influence the presentation, etiology, and outcomes in patients with acute liver failure (ALF)...
- No increased risk of myocardial infarction among patients with ulcerative colitis or Crohn's diseaseMark T Osterman
Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
Clin Gastroenterol Hepatol 9:875-80. 2011..We aimed to determine the risk of first-time acute MI in patients with ulcerative colitis (UC) or Crohn's disease (CD) compared with patients from general practice...
- Cancer incidence in The Health Improvement NetworkKevin Haynes
Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104 6021, USA
Pharmacoepidemiol Drug Saf 18:730-6. 2009..This study assessed whether the recorded incidence of cancer among patients in The Health Improvement Network (THIN) database is comparable to that expected in the UK based on national cancer registry data...
- Histologic predictors of fibrosis progression in liver allografts in patients with hepatitis C virus infectionZina Meriden
Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
Clin Gastroenterol Hepatol 8:289-96, 296.e1-8. 2010..Recurrent hepatitis C with ensuing fibrosis is the leading cause of liver allograft loss. We investigated whether histologic features in early posttransplant liver biopsies could predict the rate of fibrosis progression in this population...
- Validity of diagnostic codes to identify cases of severe acute liver injury in the US Food and Drug Administration's Mini-Sentinel Distributed DatabaseVincent Lo Re
Division of Infectious Diseases, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
Pharmacoepidemiol Drug Saf 22:861-72. 2013....
- Immunosuppressant medications and mortality in inflammatory bowel diseaseJames D Lewis
Division of Gastroenterology, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
Am J Gastroenterol 103:1428-35; quiz 1436. 2008..This study examined whether treatment of Crohn's disease (CD) and ulcerative colitis (UC) with immunosuppressant medications was associated with an increased risk of death in the era prior to antitumor necrosis factor (TNF) therapies...
- Do statins reduce hepatitis C RNA titers during routine clinical use?Kimberly A Forde
Research Section, Philadelphia Veterans Administration Medical Center, Research A402A, 3900 Woodland Avenue, Philadelphia, PA 19104, United States
World J Gastroenterol 15:5020-7. 2009..To compare hepatitis C virus (HCV) titers in patients with chronic hepatitis C with and without exposure to 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins)...
- Factors That Predict Short-term Intensive Care Unit Mortality in Patients With CirrhosisRanjeeta Bahirwani
Division of Gastroenterology and Hepatology, University of Pennsylvania, Philadelphia, Pennsylvania
Clin Gastroenterol Hepatol 11:1194-1200.e2. 2013..We aimed to identify factors that predict early (7 d) mortality among patients with cirrhosis admitted to the intensive care unit (ICU) and to develop a risk-stratification model...
- Hepatitis C virus infection and immunomodulatory therapiesKimberly A Forde
Division of Gastroenterology, Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
Clin Liver Dis 13:391-401. 2009..In this article, the authors discuss immunomodulatory therapies and clinical trials in the treatment of HCV infection...